Operating Company Healthcare

Nutrition & Health by Nestlé

Vevey, Vaud, Switzerland

Formerly known as NHSc, Nestle Health Science, Nestle Health Science (NHSc)

Nutrition & Health by Nestlé is Nestlé’s nutrition and health business, succeeding the Nestlé Health Science identity following a 2026 reorganization. Its portfolio spans science-based consumer nutrition and supplements, medical nutrition, and health-focused products and solutions.

Focus Areas
Medical nutrition, Vitamins, minerals and supplements, Science-based consumer health nutrition
Website
www.nestle.com

Tracked deals

5

5 tracked deals across 2020-2022.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

5 buyout

Nutrition & Health by Nestlé Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Nutrition & Health by Nestlé. 2 2020 2 2021 1 2022

Supporting Data

Recent Transactions

  • Buyer
    Nestlé Health Science
    Target
    Orgain
    Seller
    Dr. Andrew Abraham, Butterfly Equity
    Industry
    Food & Beverage
    Type
    Buyout

    Nestlé Health Science has agreed to acquire a majority stake in Orgain, the U.S. plant-based nutrition company, from founder Dr. Andrew Abraham and Butterfly Equity; both sellers will retain minority ownership positions. Dr. Andrew Abraham will remain CEO of Orgain and the deal will let Nestlé Health Science expand its portfolio of clean, plant-based nutrition products globally; the transaction is subject to customary regulatory approvals.

  • Buyer
    Nestlé, Nestlé Health Science
    Target
    The Bountiful Company
    Seller
    KKR, The Carlyle Group
    Industry
    Food & Beverage
    Type
    Buyout

    Nestlé (via Nestlé Health Science) agreed to acquire the core vitamin and supplement brands of The Bountiful Company from KKR and Carlyle for $5.75 billion, integrating brands such as Nature's Bounty, Solgar, Puritan's Pride and Osteo Bi‑Flex into its NHSc portfolio. The deal (expected/closed in H2 2021) brings roughly 4,000–4,500 employees into Nestlé Health Science and establishes Nestlé as a global leader in vitamins, minerals and nutritional supplements across mass retail, specialty retail and e‑commerce.

  • Buyer
    Nestlé Health Science
    Target
    Nuun
    Seller
    TSG Consumer Partners
    Location
    United States
    Type
    Buyout

    TSG Consumer Partners’ partner company Nuun has entered into an agreement to be acquired by Nestlé Health Science. Terms were not disclosed, and the transaction is expected to close in the second half of 2021.

  • Buyer
    Nestlé Health Science (NHSc), Société des Produits Nestlé S.A. (SPN), Nestlé S.A.
    Target
    Aimmune Therapeutics
    Industry
    Pharmaceuticals
    Type
    Buyout

    Nestlé Health Science (NHSc), via a Nestlé S.A. acquisition subsidiary (Société des Produits Nestlé S.A.), agreed to acquire Aimmune Therapeutics for USD34.50 per share in cash, valuing the company at approximately USD2.6 billion. NHSc already owned ~25.6% of Aimmune; the tender offer is expected to close in Q4 2020 and will expand Nestlé's portfolio with Aimmune's FDA-approved peanut allergy therapy Palforzia.

  • Buyer
    Nestlé Health Science (NHSc), Nestlé
    Target
    Vital Proteins
    Industry
    Food & Beverage
    Type
    Buyout

    Nestlé Health Science (NHSc), a subsidiary of Nestlé, agreed to acquire a majority stake in Vital Proteins, the US market leader in collagen-based supplements, beverages and food products. Vital Proteins will continue to operate as a standalone business under CEO Kurt Seidensticker, with the deal intended to accelerate global expansion and product innovation.

Related Acquisition Pages

Selling a company? Get in front of buyers like Nutrition & Health by Nestlé

Turn tracked acquisition activity into an outreach-ready buyer list.